Biogen Community Update on DEVOTE Clinical Trial

20 September 2019

Announced publicly via press release at the 13th Congress of the European Paediatric Neurology Society (EPNS), in Athens, the DEVOTE study will evaluate if higher dosing of nusinersen can provide improved efficacy in the treatment of SMA across a broad population of patients.

Read the Community Update